Sign In
Buy CTMX
$3.22
+0.0600 (+1.90%)
At Close: Jun 03, 2026
CytomX Therapeutics (CTMX) Earnings Expected to Grow: Should You Buy?
04:33pm, Thursday, 30'th Jul 2020
CytomX Therapeutics (CTMX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CytomX Therapeutics to Announce Second Quarter 2020 Financial Results
12:00pm, Tuesday, 28'th Jul 2020
-Teleconference Scheduled for August 6, 2020, at 5:30 p.m. ET-SOUTH SAN FRANCISCO, Calif., July 28, 2020 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused
Did Hedge Funds Make The Right Call On CytomX Therapeutics, Inc. (CTMX) ?
08:03pm, Monday, 20'th Jul 2020
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filin
CLASS ACTION UPDATE for CTMX, GEO and JCOM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
05:00pm, Monday, 20'th Jul 2020
NEW YORK, NY / ACESSWIRE / July 20, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.
LOS ANGELES, CA / ACCESSWIRE / July 20, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against CytomX Therapeutics, Inc.
SHAREHOLDER ALERT: CTMX ENPH GEO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
03:40pm, Monday, 20'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 20, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies.
New York, New York--(Newsfile Corp. - July 20, 2020) - Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against CytomX Therapeutics, Inc. ("CytomX" or "t
Los Angeles, California--(Newsfile Corp. - July 20, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against CytomX Therapeuti
LAWSUITS FILED AGAINST CTMX, PPC and BKD - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS
12:50pm, Monday, 20'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 20, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who
SHAREHOLDER ALERT: CTMX PPC JCOM: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
11:30am, Monday, 20'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 20, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies.
SHAREHOLDER ALERT: CTMX PPC WRCDF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
10:20am, Monday, 20'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 20, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies.
LOS ANGELES, CA / ACCESSWIRE / July 20, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against CytomX Therapeutics, Inc.
LOS ANGELES, CA / ACCESSWIRE / July 18, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against CytomX Therapeutics, Inc.
NEW YORK, NY / ACCESSWIRE / July 18, 2020 / Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CytomX Therapeutics, Inc.
New York, New York--(Newsfile Corp. - July 17, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CytomX Therapeutics, Inc. ("CytomX" or the "Company") (NASDA
